MediPacific to acquire Pardes Biosciences for $2.02-$2.19 per share in cash
PremiumThe FlyMediPacific to acquire Pardes Biosciences for $2.02-$2.19 per share in cash
1y ago
Pardes Biosciences Reports First Quarter 2023 Financial Results
Premium
Press Releases
Pardes Biosciences Reports First Quarter 2023 Financial Results
1y ago
Pardes downgraded to Market Perform from Outperform at SVB Securities
Premium
The Fly
Pardes downgraded to Market Perform from Outperform at SVB Securities
1y ago
Pardes Biosciences initiated with an Outperform at JMP Securities
PremiumThe FlyPardes Biosciences initiated with an Outperform at JMP Securities
2y ago
Pardes Biosciences Reports Third Quarter 2022 Financial Results and Provides Business Update
Premium
Press Releases
Pardes Biosciences Reports Third Quarter 2022 Financial Results and Provides Business Update
2y ago
Pardes Biosciences to Present at Jefferies London Healthcare Conference
Premium
Press Releases
Pardes Biosciences to Present at Jefferies London Healthcare Conference
2y ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100